Skip to main content
placeholder image

Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis.

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2015

Citation


  • Ryan, C. J., Smith, M. R., Fizazi, K., Saad, F., Sternberg, C. N., Logothetis, C., . . . Rathkopf, D. E. (2015). Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis.. Journal of Clinical Oncology, 33(7_suppl), 142. doi:10.1200/jco.2015.33.7_suppl.142

Web Of Science Accession Number


Start Page


  • 142

End Page


  • 142

Volume


  • 33

Issue


  • 7_suppl

Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2015

Citation


  • Ryan, C. J., Smith, M. R., Fizazi, K., Saad, F., Sternberg, C. N., Logothetis, C., . . . Rathkopf, D. E. (2015). Impact of crossover and baseline prognostic factors on overall survival (OS) with abiraterone acetate (AA) in the COU-AA-302 final analysis.. Journal of Clinical Oncology, 33(7_suppl), 142. doi:10.1200/jco.2015.33.7_suppl.142

Web Of Science Accession Number


Start Page


  • 142

End Page


  • 142

Volume


  • 33

Issue


  • 7_suppl